Las Cruces, NM, United States of America

Kathryn A Hanley



 

Average Co-Inventor Count = 5.3

ph-index = 6

Forward Citations = 82(Granted Patents)


Location History:

  • Bethesda, MD (US) (2007 - 2014)
  • Las Cruces, NM (US) (2009 - 2023)

Company Filing History:


Years Active: 2007-2023

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: **Kathryn A. Hanley: Pioneering Innovations in Dengue Vaccine Development**

Introduction

Kathryn A. Hanley, based in Las Cruces, NM, is a distinguished inventor with an impressive portfolio of 17 patents. Her groundbreaking work focuses on the development of innovative dengue virus vaccines, contributing significantly to public health research and advancements in immunology.

Latest Patents

Among her latest patents is a dengue tetravalent vaccine designed to contain a common 30 nucleotide deletion in the 3'-untranslated region of the genome of dengue virus serotypes 1, 2, 3, and 4. This invention aims to address the complexities of dengue virus infections by providing a more effective vaccination strategy. Another significant patent involves attenuated mutant dengue viruses that contain mutations in the NS5 non-structural protein, which offers a method to fine-tune the attenuation and growth characteristics of dengue virus vaccines.

Career Highlights

Throughout her career, Kathryn has collaborated with reputable institutions, including the United States of America as represented by the Secretary of the Department of Health and Human Services. Her contributions have been instrumental in the progression of vaccine technology and health protection measures against dengue fever.

Collaborations

Kathryn A. Hanley has worked alongside notable individuals in her field, including Stephen S. Whitehead and Brian R. Murphy. Their collaborative efforts have driven forward the innovations within vaccine research, showcasing the power of teamwork in scientific advancements.

Conclusion

Kathryn A. Hanley's contributions to dengue vaccine research reflect her dedication to developing effective health solutions. With her numerous patents and collaborations, she continues to shape the landscape of immunology and public health through her innovative inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…